Literature DB >> 15012737

Albumin fragments in normal rat urine are derived from rapidly degraded filtered albumin.

Steven P Clavant1, Kerryn A Greive, Julijana Nikolovski, Shane Reeve, A Ian Smith, Wayne D Comper.   

Abstract

Filtered albumin is excreted as a heterogeneous population of albumin-derived molecules resulting from degradation during renal passage. In order to understand the dynamics of this degradation process, albumin clearance was studied over a short-term (minutes) and a long-term (7 days) by both radioactivity and radioimmunoassay. The radiolabelled material in the urine was also analysed extensively by using size exclusion chromatography, size selective filtration and high performance liquid chromatography. These studies demonstrate that during renal passage, albumin degradation to fragments in the size range of 500-10,000 occurs in a matter of minutes. The fragments are not detected by using radioimmunoassay. Steady state excretion rates or fractional clearance of radiolabelled albumin occur over a similar time period. Both rates of degradation and approach to steady-state clearance, while rapid, were considerably slower than the transit time for molecules in the Bowman's capsule and early tubular lumen. The results are consistent with an extremely rapid lysosomal uptake of filtered albumin, and degradation and regurgitation of the albumin-derived peptide fragments into the tubular lumen prior to excretion.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 15012737     DOI: 10.1046/j.1440-1797.2003.00136.x

Source DB:  PubMed          Journal:  Nephrology (Carlton)        ISSN: 1320-5358            Impact factor:   2.506


  10 in total

1.  Generation of urinary albumin fragments does not require proximal tubular uptake.

Authors:  Kathrin Weyer; Rikke Nielsen; Erik I Christensen; Henrik Birn
Journal:  J Am Soc Nephrol       Date:  2012-01-26       Impact factor: 10.121

Review 2.  Microalbuminuria and C-reactive protein: similar messengers of cardiovascular risk?

Authors:  Stephan J L Bakker; Ron T Gansevoort; Erik M Stuveling; Rijk O B Gans; Dick de Zeeuw
Journal:  Curr Hypertens Rep       Date:  2005-10       Impact factor: 5.369

3.  Albumin handling by renal tubular epithelial cells in a microfluidic bioreactor.

Authors:  Nicholas Ferrell; Kevin B Ricci; Joseph Groszek; Joseph T Marmerstein; William H Fissell
Journal:  Biotechnol Bioeng       Date:  2011-11-10       Impact factor: 4.530

4.  Urinary biomarkers for monitoring disease progression in the Han:SPRD-cy rat model of autosomal-dominant polycystic kidney disease.

Authors:  Charles E Wiedmeyer; Angela B Royal
Journal:  Comp Med       Date:  2010-12       Impact factor: 0.982

Review 5.  Proteomics and diabetic nephropathy.

Authors:  Michael L Merchant; Jon B Klein
Journal:  Curr Diab Rep       Date:  2005-12       Impact factor: 4.810

6.  Presence of immunounreactive albumin in the urine of diabetic patients.

Authors:  Aki Nakayama; Takashi Ida; Yoshiji Hatano; Kayoko Oohara; Hiroshi Yoshida; Toshiaki Baba; Hisashi Sakamoto; Kiyoko Shiba
Journal:  J Clin Lab Anal       Date:  2006       Impact factor: 2.352

7.  Predictors of urinary albumin excretion in women with polycystic ovary syndrome.

Authors:  Antoni J Duleba; Ibrahim M Ahmed
Journal:  Fertil Steril       Date:  2009-02-12       Impact factor: 7.329

8.  Imaging mass spectrometry reveals direct albumin fragmentation within the diabetic kidney.

Authors:  Kerri J Grove; Nichole M Lareau; Paul A Voziyan; Fenghua Zeng; Raymond C Harris; Billy G Hudson; Richard M Caprioli
Journal:  Kidney Int       Date:  2018-05-18       Impact factor: 10.612

Review 9.  Albumin uptake and processing by the proximal tubule: physiological, pathological, and therapeutic implications.

Authors:  Bruce A Molitoris; Ruben M Sandoval; Shiv Pratap S Yadav; Mark C Wagner
Journal:  Physiol Rev       Date:  2022-04-04       Impact factor: 46.500

10.  Spatiotemporal organisation of protein processing in the kidney.

Authors:  Marcello Polesel; Monika Kaminska; Dominik Haenni; Milica Bugarski; Claus Schuh; Nevena Jankovic; Andres Kaech; Jose M Mateos; Marine Berquez; Andrew M Hall
Journal:  Nat Commun       Date:  2022-09-29       Impact factor: 17.694

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.